Point-of-care paper-based analytical device for potentiometric detection of myoglobin as a cardiovascular disease biomarker
Abdulrahman A. Almehizia, Ahmed M. Naglah, Lamees S. Al-Rasheed, Mashael G. Alanazi, Abdel El-Galil E. Amr, Ayman H. Kamel
Abstract
= 0.9998) and a detection limit of 28 nM at pH 4. Compared to creatinine, sucrose, fructose, galactose, sodium glutamate, thiamine, alanine, ammonium, uric acid, albumin, glutamine, guanine, troponine T, and glucose, the sensor showed good selectivity for Mb. It demonstrated a good recovery for the detection of Mb in several fake serum samples (93.0-103.3%), with an average relative standard deviation of 4.5%. The current approach might be viewed as a potentially fruitful analytical tool for obtaining disposable, cost-effective paper-based potentiometric sensing devices. These types of analytical devices can be potentially manufacturable at large scales in clinical analysis.